Our Pricing

Understanding Wegovy UK Private Prescription Access and Genuine Novo Nordisk Supply

Accessing wegovy uk private prescription services has become increasingly popular as patients seek reliable weight management solutions outside NHS waiting lists. Cured Pharmacy provides genuine Novo Nordisk Wegovy (semaglutide) from £69.00, with full clinical assessment by UK-registered prescribers and guaranteed authenticity. Every private prescription undergoes the same rigorous safety checks as NHS services, ensuring appropriate patient selection and ongoing monitoring.

How Wegovy UK Private Prescriptions Work

The wegovy uk private prescription pathway begins with a comprehensive online clinical assessment reviewed by UK-registered prescribers. At Cured Pharmacy, this consultation takes under three minutes and evaluates your BMI, medical history, current medications, and weight loss goals to determine suitability for semaglutide treatment [1]. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees every prescription to ensure compliance with MHRA guidelines and patient safety standards.

Once approved, your genuine Novo Nordisk Wegovy is dispensed from our UK-registered pharmacy (GPhC 9012511) with discreet next-day delivery. Private prescriptions provide flexibility in dosing schedules and remove the uncertainty of NHS supply shortages, giving patients consistent access to their treatment [2]. Every pen is sourced directly from licensed UK wholesalers, guaranteeing authenticity and proper cold-chain storage throughout the supply process.

Clinical Assessment Requirements for Private Wegovy

UK prescribers assess wegovy uk private candidates using strict clinical criteria including BMI thresholds (≥30 kg/m² or ≥27 kg/m² with weight-related comorbidities), cardiovascular risk factors, and contraindications such as personal or family history of medullary thyroid carcinoma [3]. The assessment also reviews concurrent medications for potential interactions, particularly with insulin or sulfonylureas where dose adjustments may be necessary to prevent hypoglycaemia.

Wegovy UK Private Pricing and Genuine Novo Nordisk Guarantee

Cured Pharmacy offers wegovy uk private prescriptions from £69.00, representing the cheapest UK price for genuine Novo Nordisk semaglutide injections. This transparent pricing includes the medication, clinical assessment, and UK prescriber review, with no hidden consultation fees. New patients Save £20 using code Weightlossnew on their first order, making the initial month even more affordable.

Every Wegovy pen supplied carries Novo Nordisk's authentication features including holographic labels, batch number verification, and tamper-evident packaging. We guarantee 100% genuine medication sourced exclusively through MHRA-licensed UK distribution channels, never parallel imports or grey market supplies [4]. Patients receive the same pharmaceutical-grade semaglutide used in the landmark STEP clinical trials, ensuring consistent efficacy and safety profiles.

Wegovy UK Private Dosing Schedule and Treatment Duration

The wegovy uk private prescription follows Novo Nordisk's evidence-based dose escalation protocol, starting at 0.25 mg weekly for four weeks. This gradual titration minimises gastrointestinal side effects while allowing physiological adaptation to GLP-1 receptor agonism [5]. The schedule progresses through 0.5 mg, 1.0 mg, 1.7 mg, reaching the maintenance dose of 2.4 mg by week 17.

Clinical trials demonstrated that patients achieving the 2.4 mg maintenance dose experienced average weight loss of 14.9% over 68 weeks, compared to 2.4% with placebo in the STEP 1 trial [1]. However, individual results vary based on adherence, dietary modifications, and baseline metabolic factors. UK prescribers recommend remaining on the maintenance dose for at least 12 months to achieve optimal metabolic benefits and weight stabilisation.

Managing Side Effects During Dose Escalation

The most common side effects during wegovy uk private treatment include nausea (44% of patients), diarrhoea (30%), and constipation (24%), predominantly occurring during dose escalation phases [5]. These gastrointestinal effects typically resolve within 4-8 weeks as the body adapts to increased GLP-1 activity. Our clinical team provides detailed guidance on dietary strategies including smaller portion sizes, avoiding high-fat meals, and adequate hydration to minimise discomfort during titration.

Wegovy UK Private Supply Reliability and Stock Availability

Unlike NHS services affected by national supply constraints, wegovy uk private prescriptions through Cured Pharmacy maintain consistent stock availability through diversified wholesale partnerships. We monitor Novo Nordisk production schedules and UK distribution patterns to ensure uninterrupted patient access across all dose strengths. Our pharmacy holds appropriate refrigerated storage facilities maintaining the required 2-8°C temperature range for semaglutide stability.

Patients receive real-time stock updates before completing their clinical assessment, preventing the frustration of approved prescriptions without available medication. This reliability proves particularly important for patients mid-titration, where dose interruptions can necessitate restarting the escalation schedule from lower strengths [2]. Our dispensing team coordinates delivery timing to ensure seamless transitions between dose strengths according to your prescribed schedule.

Clinical Evidence Supporting Wegovy UK Private Prescriptions

The wegovy uk private prescription pathway is supported by robust clinical evidence from the STEP trial programme, encompassing over 4,500 participants across multiple studies. STEP 1 demonstrated that 86.4% of patients on semaglutide 2.4 mg achieved ≥5% weight loss compared to 31.5% on placebo, with 50.5% achieving ≥15% weight loss versus 4.9% placebo [1]. These results established semaglutide as the most effective pharmacological weight management option currently licensed in the UK.

Beyond weight reduction, STEP trials revealed significant improvements in cardiometabolic markers including HbA1c reductions averaging 0.45%, systolic blood pressure decreases of 6.2 mmHg, and improvements in lipid profiles [6]. The STEP 5 trial extended follow-up to 104 weeks, demonstrating sustained weight loss maintenance and continued metabolic benefits with ongoing treatment. UK prescribers consider this comprehensive evidence base when recommending wegovy uk private prescriptions for appropriate candidates.

Long-term Safety Profile from Clinical Trials

Extended safety data from the STEP programme showed no increased risk of serious adverse events with semaglutide 2.4 mg compared to placebo over two years of treatment [6]. The most significant safety consideration remains the theoretical risk of thyroid C-cell tumours observed in rodent studies, leading to contraindication in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. UK prescribers conduct thorough thyroid history assessment during every wegovy uk private consultation to identify at-risk individuals.

Wegovy UK Private Treatment Monitoring and Ongoing Support

Patients receiving wegovy uk private prescriptions through Cured Pharmacy access ongoing clinical support throughout their treatment journey. Our UK prescribers review progress at each prescription renewal, assessing weight loss trajectory, side effect management, and any emerging contraindications. This structured monitoring ensures treatment remains appropriate and effective, with dose adjustments or discontinuation recommended if patients fail to achieve ≥5% weight loss after 12 weeks on the maintenance dose, following NICE guidance principles.

The clinical team provides evidence-based lifestyle counselling alongside pharmacotherapy, recognising that semaglutide works synergistically with dietary modification and increased physical activity [3]. Patients receive access to our pharmacist-led support line for questions about injection technique, side effect management, or dose timing. This comprehensive approach mirrors best-practice weight management programmes, optimising outcomes beyond medication alone. Regular monitoring also identifies rare adverse events early, including pancreatitis symptoms or gallbladder complications requiring immediate medical attention.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
2. Medicines and Healthcare products Regulatory Agency. (2023). Semaglutide 2.4 mg (Wegovy) supply update for healthcare professionals. GOV.UK. [accessed 15 August 2026]
3. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE guidance. [accessed 15 August 2026]
4. General Pharmaceutical Council. (2022). Guidance on the sale and supply of medicines. GPhC professional standards. [accessed 15 August 2026]
5. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. [accessed 15 August 2026]
6. Garvey, W. T., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen, L. N., Frias, J. P., ... & Wharton, S. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083-2091. [accessed 15 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.